Continuing Education

  • Lunch Series

    Second Thursday of every month from 12:00pm – 1:00pm

    Online via Zoom

    The West Virginia University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The WVU Office of CME designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    This continuing education activity has been provided by the West Virginia University School of Nursing for 1.2 contact hours. The West Virginia University School of Nursing is an approved provider of continuing education by the State of West Virginia Board of Examiners for Registered Professional Nurses, Legislative Rule § 19CSR11-4 under provider number 50-26086

    This continuing education activity has been approved for 1 hour of Social Work continuing education through Provider Number 490038(WVU Department of Behavioral Medicine and Psychiatry.)

    This training is approved by the State of West Virginia Board of Examiners of Psychologists for 1 continuing education hour.

    ADHD is one of the most common neurobehavioral disorders in children. The prevalence of ADHD in West Virginia is much higher than the national average. There has been shown to be a shortage of mental health professionals in the state and an overall need for clinician education on evidence-informed evaluation, diagnosis, and treatment of ADHD.

    August 8th – Lunch Seminar Flyer



General disclaimer:
This content is not intended to address all possible diagnosis methods, treatments, follow up, drugs or their related contraindications or side effects. Standards of practice change as new data becomes available. Therefore, it is strongly recommended that practitioners independently assess and verify diagnosis, treatments and drugs for each individual patient. The authors of the WV ACC guidelines assume no liability for any aspect of treatment administered by a practitioner with the aid of this publication.

Drug disclaimer:
The authors do not endorse or recommend the use of any particular drug mentioned in this publication. Before prescribing a new drug to a patient, practitioners are advised to check the product information accompanying each drug to ensure it is appropriate for a specific patient and to identify appropriate dosage, contraindications, side effects and drug-to-drug interactions.

Standard of care disclaimer:
This publication is not intended to establish a standard of care applicable to practitioners who treated patients diagnosed with ADHD. “Standard of care” is a legal term, not a medical term, which refers to the degree of care a reasonable practitioner would exercise under the same or similar circumstances. The standard of care is a continuum and does not imply optimal care. Practitioner discretion and clinical judgment are paramount and this publication is only intended to aid practitioners’ judgment, not to serve as a substitute for said judgment.